Panama - Inggris - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios richet, s.a. - imipenem anhidro (monohidrato) - imipenem anhidro (monohidrato)....500.00 mg / cilastatina Ácido (sal sÓdica)....500.00 mg

Singapura - Inggris - HSA (Health Sciences Authority)

aguettant asia pacific pte. ltd. - sodium valproate - injection, solution - sodium valproate 400mg/4ml

Filipina - Inggris - FDA (Food And Drug Administration)

ambica international corporation; distributor: ambica international corporation - imipenem (as monohydrate) , cilastatin (as sodium) - powder for injection (i.v.) - 500 mg/500 mg

Filipina - Inggris - FDA (Food And Drug Administration)

jlt pharma, inc.; distributor: jlt pharma, inc. - imipenem (as monohydrate) , cilastatin (as sodium) - powder for injection (iv) - 500 mg/500 mg

Filipina - Inggris - FDA (Food And Drug Administration)

amb hk enterprises inc.; distributor: amb hk enterprises inc. - imipenem (as monohydrate) , cilastatin (as sodium) - powder for injection (i.v.) - 500 mg/500 mg

Malaysia - Inggris - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

unimed sdn bhd - cilastatin sodium; imipenem -

Filipina - Inggris - FDA (Food And Drug Administration)

eon pharmatek inc.; distributor: eon pharmatek inc. - piperacillin (as sodium) , tazobactam (as sodium) - powder for iv injection - 4 g/500 mg

Amerika Serikat - Inggris - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - divalproex sodium (unii: 644vl95ao6) (valproic acid - unii:614oi1z5wi) - valproic acid 250 mg - divalproex sodium is a valproate and is indicated for the treatment of the manic episodes associated with bipolar disorder. a manic episode is a distinct period of abnormally and persistently elevated, expansive, or irritable mood. typical symptoms of mania include pressure of speech, motor hyperactivity, reduced need for sleep, flight of ideas, grandiosity, poor judgment, aggressiveness, and possible hostility. the efficacy of divalproex sodium was established in 3 week trials with patients meeting dsm-iii-r criteria for bipolar disorder who were hospitalized for acute mania [see clinical studies (14.1)] . the safety and effectiveness of divalproex sodium for long-term use in mania, i.e., more than 3 weeks, has not been demonstrated in controlled clinical trials. therefore, healthcare providers who elect to use divalproex sodium for extended periods should continually reevaluate the long-term usefulness of the drug for the individual patient. divalproex sodium delayed-release tablets are indicated as monothe

Amerika Serikat - Inggris - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - divalproex sodium (unii: 644vl95ao6) (valproic acid - unii:614oi1z5wi) - valproic acid 250 mg - divalproex sodium extended-release tablets are a valproate and are indicated for the treatment of acute manic or mixed episodes associated with bipolar disorder, with or without psychotic features. a manic episode is a distinct period of abnormally and persistently elevated, expansive, or irritable mood. typical symptoms of mania include pressure of speech, motor hyperactivity, reduced need for sleep, flight of ideas, grandiosity, poor judgment, aggressiveness, and possible hostility. a mixed episode is characterized by the criteria for a manic episode in conjunction with those for a major depressive episode (depressed mood, loss of interest or pleasure in nearly all activities). the efficacy of divalproex sodium extended-release tablets is based in part on studies of divalproex sodium delayed-release tablets in this indication, and was confirmed in a 3-week trial with patients meeting dsm-iv tr criteria for bipolar i disorder, manic or mixed type, who were hospitalized for acute mania [see clinical studies (

Amerika Serikat - Inggris - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - divalproex sodium (unii: 644vl95ao6) (valproic acid - unii:614oi1z5wi) - valproic acid 125 mg - divalproex sodium delayed-release tablets are a valproate and are indicated for the treatment of the manic episodes associated with bipolar disorder. a manic episode is a distinct period of abnormally and persistently elevated, expansive, or irritable mood. typical symptoms of mania include pressure of speech, motor hyperactivity, reduced need for sleep, flight of ideas, grandiosity, poor judgment, aggressiveness, and possible hostility. the efficacy of divalproex sodium delayed-release tablets was established in 3 week trials with patients meeting dsm-iii-r criteria for bipolar disorder who were hospitalized for acute mania [see clinical studies (14.1)]. the safety and effectiveness of divalproex sodium delayed-release tablets for long-term use in mania, i.e., more than 3 weeks, has not been demonstrated in controlled clinical trials. therefore, healthcare providers who elect to use divalproex sodium delayed-release tablets for extended periods should continually reevaluate the long-term usefulness of the dr